## VCYT: Veracyte, Inc. - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.78 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($38.29)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Moderate Buy" by Brokerages**
- Source: MarketBeat | 20251215T151018 | Somewhat-Bullish | Relevance: 100%
- Veracyte, Inc. (NASDAQ:VCYT) has received an average "Moderate Buy" rating from nine brokerages, with a consensus 1-year price target of $45.43. Despite recent insider selling totaling $5.9 million, the company reported strong Q3 earnings, beating EPS and revenue estimates. Various institutional investors have adjusted their holdings, and the stock currently trades with a market cap of $3.39 billion.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $48 | $40 | +20% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 26 ($5.85M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 70.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Blackrock Inc.: 16.5% (+68.9%)
- Vanguard Group Inc: 10.8% (+5.0%)
- Artisan Partners Lim: 9.3% (+16.6%)
- FMR, LLC: 8.6% (-16.2%)
- ARK Investment Manag: 5.7% (+17.5%)

### Key Risks

1. High beta (1.83) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Insider selling cluster: $5.8M in recent transactions.
3. Elevated short interest (8.1%): bears positioning against stock.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.78 indicates undervaluation relative to growth. Balance sheet: strong liquidity (6.2x), low leverage (D/E 0.09). Analyst sentiment positive (1 raises, avg +20%). Insider selling cluster ($5.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $3.3B |
| Beta | 1.83 |
| 52W Range | $22.61 - $50.71 |
| Short Interest | 8.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.78 |
| Forward P/E | 26.3 |
| Current P/E | 25.6 |
| YoY Growth | -2.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -6.0% to -3.6% (+2.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 7.6pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.5%) - potential reversal signal. AM_20 at -5.5% indicates price below own 20MA trend. Underperforming sector by 5.3pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.31x) but short-term weakness (below SMA20). MACD histogram bearish (-0.68), momentum weakening. RSI neutral at 47. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.63% (CS: 13) | Weak |
| RSI_14 | 47.3 | Neutral |
| MACD Histogram | -0.68 | Bearish |
| vs SMA20 | 0.945x | Below |
| vs SMA50 | 1.046x | Above |
| vs SMA200 | 1.314x | Above |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $42.21
- **Stop Loss:** $38.29 (9.3% risk)
- **Target:** $50.05 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 275
- **Position Value:** $11,607.75
- **Portfolio %:** 11.61%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-24 (Est: $0.39)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.32 | $0.51 | +59.5% |
| 2025Q2 | $0.30 | $0.44 | +48.5% |
| 2025Q1 | $0.20 | $0.31 | +51.3% |
| 2024Q4 | $0.26 | $0.36 | +40.0% |

---
*RULE-based L3 | 2026-01-07 01:41 | MRS_20*